Would you like to receive Hot Stock updates like this? If so click here to sign up!

Quote Charts News  Web Site Investors         Thursday December 6, 2007

RECENT NEWS

12/04/07 Shazamstocks Announces Profile Launch of Edgeline Holdings

 12/04/07 Edgeline Holdings Announces the Acquisition of Intertech Bio Has Been Completed

11/01/07 Edgeline Holdings Completes the Field Testing of Its Potential Technology Acquisition

10/30/07 Edgeline Holdings Announces It Has Executed a $10M Funding Term Sheet

10/17/07: Edgeline Holdings Announces Receipt of $7.5M Funding Proposal

10/15/07: Edgeline Holdings to Close on Its Acquisition of Intertech Bio

10/11/07: Edgeline Holdings Schedules Field Testing of Its Potential Acquisition Which Addresses the Multi-Billion-Dollar Enhanced Oil Recovery Industry

09/18/07: Edgeline Holdings' Subsidiary, New EnerSource, Enters Due Diligence Phase on Its Potential Acquisition of an Enhanced Oil Recovery Technology

09/12/07: Equity Stock Analysis Announces Research Coverage of Edgeline Holdings with a Rating of ''Attractive'' and a Price  of $1.50

After the market closed on Wednesday December 5th,

Edgeline Holdings Signs Exclusive Option Agreement with the University of Texas M. D. Anderson Cancer Center!

Having just announced that it has completed the acquisition of Intertech Bio Corporation, Edgeline Holdings, Inc. (OTCBB: ELHI) should have investors keeping their eyes on the company this morning. Yesterday after the markets closed, the company, which specializes in the area of discovering and acquiring leading-edge niche technologies, issued a press release announcing that it has signed an Option agreement with The University of Texas M. D. Anderson Cancer Center that provides Edgeline Holdings the exclusive right to negotiate a license to five technologies relating to the treatment of various cancers over a nine month period.

More great news for the company, as the press release states that during this period, the company has the right to evaluate the patents rights, potential products and markets, and to negotiate a license for the use of these patents.

This agreement gives us the necessary time to allow our subsidiary, Intertech Bio, to properly evaluate the potential of these technologies. stated Leonard Ivins, Chief Executive Officer of Edgeline Holdings. M. D. Anderson has been a leader in developing new cancer therapies and we are excited about the opportunity to work with such a great institution.

Wall Street News Alert is continuing to alert investors to monitor the progress of the Edgeline Holdings! It was just this week that the company reported it has completed the acquisition of Intertech Bio Corporation. Intertech Bio currently focuses on developing novel cancer treatments specifically targeting the brain, pancreatic and ovarian tumors. Intertech Bio will be moving to offices near the Texas Medical Center in Houston, Texas which is home to some of the most premier cancer treatment centers in the world.

According to the press release, Intertech Bio s medical team has many years developing and working with new cancer therapies, several which are currently in various stages of obtaining FDA approval. This team is founded by Dr. Waldemar Priebe who is a Professor of Medicinal Chemistry, Department of Experimental Therapeutics at The University of Texas, M.D. Anderson Cancer Center located in Houston, Texas and Dr. Timothy Madden who is the Director of The University of Texas M.D. Anderson Cancer Center, Pharmaceutical Development Center located in Houston, Texas.

Edgeline Holdings, Inc. offers investors attractive returns and their targeted business owners a compelling exit strategy. Their focus reflects the overall nature of an economy focused increasingly on the use of technology for cutting edge innovations.

Edgeline Holdings, Inc. offers a direct way for a shareholder to participate in innovative new technologies coming to the market in the nascent stages in multiple disciplines. Edgeline has targeted highly fragmented industries with strong growth potential.

Edgeline brings its extensive business background in entering and advising in all aspects of business development and growth to the targeted companies. This includes business and strategic planning, legal counsel, accounting/tax, human resources, strategic partnerships, marketing and PR, financing, grant preparation, insurance and risk management.

This investment model creates a compelling form of investment which provides the shareholder to essentially become an entrepreneur in advanced technology supported by a disciplined investment strategy.

Targets for acquisition are typically evaluated in a three stage process -- from generating deal flow, screening potential candidates and assessing seller interest.

Three Company Investments of Edgeline Holdings, Inc.
 Secure Voice Communications, Inc.
Intertech Bio Corporation.
New Enersource, Inc.
The great commonality of each of these enterprises is that our economy requires the cutting edge technology and innovations represented by each of these companies.

Secure Voice Communications should have its Beta version of ALAS ready for roll-out and pilot site testing at strategic customer sites very soon. ALAS addresses a VoIP area with security breach deficiencies and poor defenses. ALAS detects a subset of VoIP attacks, known as flood attacks which make the target unable to maintain the intended service level in the IP telephony protocols. Given the world-wide boom in VoIP and IP Telephony, Secure Voice's addressable market is the worldwide commercial ($14.6B) and enterprise communications sector.

Intertech Bio Corporation is a biopharmaceutical company with a primary focus on developing products to treat cancer, infectious diseases and other medical conditions associated with compromised immune systems. The Burrill Biotech Select Index closed August up 4.4% ahead of the Dow's 1% gain and NASDAQ's 2% increase.

New Enersource is focused on enhanced IMAGE recovery technology. The Task Force established by the U.S. Secretary of Energy in March 2006 directly ties our country s economic stability to the success of enhanced oil recovery. It is undisputed that this technology is as crucial and fundamental to the oil industry as drilling or refining.

Edgeline Holdings, Inc. specializes in the area of discovering and acquiring leading edge niche technologies. Edgeline incubates and nurtures these nascent technologies and companies into market ready applications.

Edgeline Holdings' current and prospective portfolio consists of early stage companies that require management expertise to further develop the technology. It is anticipated the maximizing the value of technologies when brought to market through licensing arrangements and partnerships will generate significant returns to the shareholders. Edgeline through its employees, consultants and partners is actively involved in these sectors:

VoIP and IP Telephony, Biotech & Enhanced Oil Recovery

 Certified Financial Analyst Kris Gupta Releases Report On ELHI With A Target Price Of $1.50
 click to read the full report